Cargando…
艾曲泊帕治疗成人原发免疫性血小板减少症停药后疗效维持及预测因素
OBJECTIVE: To determine the efficacy of eltrombopag for primary immune thrombocytopenia（ITP）in adults and the predictive factors for treatment-free response（TFR）. METHODS: Clinical data of adults with ITP who received eltrombopag from June 14, 2013 to May 31, 2021 in the Hematology Department of Rui...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067367/ https://www.ncbi.nlm.nih.gov/pubmed/36987720 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.01.006 |